Smitha Jagadish

Vice President, Head Of Rare Diseases And New Modalities at BIAL

Smitha Jagadish is currently the Vice President and Head of Rare Diseases and New Modalities at BIAL. Prior to this role, Smitha held positions at Grünenthal Group, Sanofi Genzyme, Whitehead Institute, University of California San Francisco, and Columbia University Medical Center. Smitha's research has focused on various aspects of neuroscience, including amyloid deposition in Alzheimer's disease, reward learning, motor performance, neural circuits, and neurodegenerative diseases. Smitha holds a Ph.D. in Neuroscience from Columbia University.

Location

Boston, United States

Links

Previous companies

Columbia University logo
Grünenthal Group logo
Sanofi logo



Offices

This person is not in any offices